Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Melanoma survivor T.J. Sharpe shares why patients should know their treatment options.

Ron Hollander, president of the International Neuroendocrine Cancer Alliance, talks to us about patient advocacy.

John Hadcock’s wife Laura gave him an ultimatum: Run the energy out of Sunny, the new puppy, or take her back to the breeder. So Hadcock started running. On his first trip out, he had to stop half a mile in.

Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.

Groups of people doing communal exercises are an everyday sight in Japan, but for one woman they are a very public way to show she is fighting back.

Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.

We surveyed 7,000 people in seven countries to find out what they know about multiple sclerosis (MS). Our survey identified several surprising misconceptions.

Learn about how digital is changing the face of patient advocacy.